XNYS
MPT
Market cap1.88bUSD
Oct 08, Last price
3.19USD
1D
-1.24%
1Q
-29.27%
Jan 2017
-74.07%
IPO
-71.08%
Name
Medical Properties Trust Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2003, Medical Properties Trust, Inc. (MPT) functions as a self-managed real estate investment trust (REIT), primarily focused on acquiring and developing hospital properties under net-lease arrangements. From its humble beginnings in Birmingham, Alabama, MPT has expanded significantly, becoming a leading global proprietor of hospital assets. Its extensive, pro forma portfolio now boasts 431 facilities, encompassing approximately 43,000 licensed beds across nine different countries and four continents. MPT's unique financing approach empowers hospital operators to undertake new acquisitions and recapitalize their holdings, effectively unlocking the capital within their real estate to finance critical facility enhancements, technological advancements, and other operational investments.
Related entities
Subsidiaries (34)
MPT ABERDEEN LTD
MPT ARNOLD LTD
MPT BASINGSTOKE LTD
MPT BECKENHAM LTD
MPT BIDDENHAM LTD
MPT CANTERBURY LTD
MPT CARMARTHEN LTD
MPT CHEADLE LTD
MPT COLOMBIA TRS SL
MPT COMBE DOWN LTD
MPT CROYDON LTD
MPT DORCHESTER LTD
MPT DROITWICH SPA LTD
MPT FULWOOD LTD
MPT GLASGOW LTD
MPT GREAT MISSENDEN LTD
MPT GUILDFORD LTD
MPT HARROW LTD
MPT HENDON LTD
MPT MILTON KEYNES LTD
Key people
Edward K. Aldag
Chairman of the Board, President, Chief Executive Officer · since 2005
Emmett E. McLean
Chief Operating Officer, Executive Vice President, Secretary · since 2017
Tim Berryman
Director � Investor Relations · since 2014
Independent Director · since 2004
Elizabeth N. Pitman
Independent Director · since 2018
Daniel Paul Sparks
Independent Director · since 2014
Michael G. Stewart
Lead Independent Director · since 2017
IPO date
Jul 08, 2005
Employees
119
Domiciled in
US
Incorporated in
US
Legal address
C/O THE CORPORATION TRUST INCORPORATED
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093
US
2405 YORK ROAD
SUITE 201
LUTHERVILLE TIMONIUM, MD 21093
US
Headquarters
SUITE 9E
11 EAST CHASE STREET
BALTIMORE, MD 21202
US
11 EAST CHASE STREET
BALTIMORE, MD 21202
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||